International Journal of Nanomedicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2025-05-21 ms2000000177905543 来自黑龙江省

投稿命中率:50.0
经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？

3 0

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2022-02-15 Pancake98

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：纳米医学
经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。

126 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2022-07-22 ms3000000979708654

2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？

81 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2025-02-22 zhaonafan 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：外泌体
经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2025-01-07 黑八一小郑来自贵州省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：皮肤癣;纳米新制剂
经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。

20 0

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2024-11-16 ms1000001788822136 来自上海

文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2024-11-14 ms7000001532187009 来自浙江省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：外泌体
经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2024-09-09 还没想好叫啥名来自吉林省

偏重的研究方向：生物材料;外泌体
经验分享：1ab合规性检查什么意思？

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2024-04-05 ms4000000135168579 来自江苏省

我的1a16天了还没动静

88 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2265988, encodeId=3b482265988c2, content=投稿命中率:50.0 经验分享：大家4C状态都等了多久啊，进入4C状态退稿的几率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226f8344052, createdName=ms2000000177905543, createdTime=Wed May 21 12:17:15 CST 2025, time=2025-05-21, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1193628, encodeId=eabd1193628e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米医学 经验分享：编辑非常专业、友好！很愉快的一次投稿经历。7月中旬投，中间确实等了一段时间，8月给大修，9月中旬就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=yJTJyibLiaKvmoYqKz72QVzA&s=100&t=1582900392, createdBy=2ab25314295, createdName=Pancake98, createdTime=Tue Feb 15 15:00:44 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2253085, encodeId=344622530852e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：10.22投的稿，初始审查比较严格，先是修改了一些伦理的表述。返回之后，编辑要求上传所有WB的原始数据，包括附图，这部分内容来回邮件发了3轮才达到要求。后续11.18送审,12.16修回，给三周修改时间。两个审稿人，提的问题不多，但是其中一个审稿人纠结样本量，另一个审稿人很nice，提了一些文字修改的意见。我们补充了样本量，修改了文字书写。12.30提交修回文章及数据。25.1.15号编辑发邮件让修改了一点小细节。1.28号发邮件接收，未二次送审。后续交版面费，修订都比较快，25.2.5 online。整体还是比较流畅。感觉每一步都有对应的编辑，每个编辑都很认真。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=296b1740450, createdName=zhaonafan, createdTime=Sat Feb 22 13:29:20 CST 2025, time=2025-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2247000, encodeId=777f224e00072, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：皮肤癣;纳米新制剂 经验分享：本来5月初投的drug design，development and therapy,后来8月建议转头international journal of nanomedicine.8月18日编辑帮忙转过来，11月初收到了6个审稿人的意见，让修改，认认真真修改了1个月，期间各种工作耽误。12月4日返回，中间17日经历1次修改标点符号的小要求，然后返回。25年元旦收到了5ab状态认为比较稳妥，3号收到了接收通知。大概就这么个过程，这个杂志很注重创新性和实验完整性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b21705152, createdName=黑八一小郑, createdTime=Tue Jan 07 21:18:55 CST 2025, time=2025-01-07, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2237316, encodeId=47df223e31637, content=文章的审稿周期在1-3个月左右，期刊的接受率相对较低，大约在21%-22%之间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:27:23 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2236992, encodeId=f5b62236992fb, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：6月中旬投稿，11月接收，编辑和审稿速度较慢，意见详细。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca09117198, createdName=ms7000001532187009, createdTime=Thu Nov 14 21:54:44 CST 2024, time=2024-11-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2224879, encodeId=fc1622248e93c, content=偏重的研究方向：生物材料;外泌体 经验分享：1ab合规性检查什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/LGwYqgmFoyap9audhicmId1AYQCcnIVvAoAmdHmiajX9k5WVHDIlgiax3TlicR1HribCXAmfNV314FmY5NEboJFaMrg/132, createdBy=473a5250569, createdName=还没想好叫啥名, createdTime=Mon Sep 09 18:31:48 CST 2024, time=2024-09-09, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2197072, encodeId=45c9219e07228, content=我的1a16天了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9ce9244713, createdName=ms4000000135168579, createdTime=Fri Apr 05 19:19:05 CST 2024, time=2024-04-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156902, encodeId=968a215690265, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：4B了已经一个月了。大佬们这是什么情况啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 19:59:52 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省)]

2023-09-09 14503317m86暂无昵称来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：纳米材料;纳米医学
经验分享：4B了已经一个月了。大佬们这是什么情况啊？

100 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务